nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP1A2—type 2 diabetes mellitus	0.169	0.602	CbGaD
Aprepitant—CYP3A4—type 2 diabetes mellitus	0.112	0.398	CbGaD
Aprepitant—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0214	0.0471	CbGbCtD
Aprepitant—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0214	0.0471	CbGbCtD
Aprepitant—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0201	0.0442	CbGbCtD
Aprepitant—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0197	0.0433	CbGbCtD
Aprepitant—CYP2C9—Glipizide—type 2 diabetes mellitus	0.018	0.0396	CbGbCtD
Aprepitant—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0171	0.0376	CbGbCtD
Aprepitant—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0171	0.0376	CbGbCtD
Aprepitant—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0167	0.0368	CbGbCtD
Aprepitant—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0161	0.0353	CbGbCtD
Aprepitant—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0158	0.0347	CbGbCtD
Aprepitant—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0152	0.0335	CbGbCtD
Aprepitant—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0146	0.032	CbGbCtD
Aprepitant—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0142	0.0313	CbGbCtD
Aprepitant—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0142	0.0313	CbGbCtD
Aprepitant—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0131	0.0289	CbGbCtD
Aprepitant—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0128	0.0282	CbGbCtD
Aprepitant—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0127	0.0279	CbGbCtD
Aprepitant—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0116	0.0255	CbGbCtD
Aprepitant—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0115	0.0252	CbGbCtD
Aprepitant—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0114	0.0252	CbGbCtD
Aprepitant—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0108	0.0239	CbGbCtD
Aprepitant—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0108	0.0237	CbGbCtD
Aprepitant—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0105	0.023	CbGbCtD
Aprepitant—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0103	0.0227	CbGbCtD
Aprepitant—CYP3A5—Losartan—type 2 diabetes mellitus	0.00993	0.0218	CbGbCtD
Aprepitant—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00914	0.0201	CbGbCtD
Aprepitant—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00875	0.0193	CbGbCtD
Aprepitant—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00827	0.0182	CbGbCtD
Aprepitant—CYP2C19—Losartan—type 2 diabetes mellitus	0.00801	0.0176	CbGbCtD
Aprepitant—CYP1A2—Losartan—type 2 diabetes mellitus	0.00739	0.0163	CbGbCtD
Aprepitant—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00728	0.016	CbGbCtD
Aprepitant—CYP2C9—Losartan—type 2 diabetes mellitus	0.00666	0.0146	CbGbCtD
Aprepitant—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00627	0.0138	CbGbCtD
Aprepitant—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00601	0.0132	CbGbCtD
Aprepitant—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00601	0.0132	CbGbCtD
Aprepitant—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00568	0.0125	CbGbCtD
Aprepitant—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00423	0.00931	CbGbCtD
Aprepitant—CYP3A4—Losartan—type 2 diabetes mellitus	0.00387	0.00852	CbGbCtD
Aprepitant—TACR1—peripheral nervous system—type 2 diabetes mellitus	0.00301	0.232	CbGeAlD
Aprepitant—TACR1—nerve—type 2 diabetes mellitus	0.00235	0.181	CbGeAlD
Aprepitant—TACR3—cardiovascular system—type 2 diabetes mellitus	0.00212	0.163	CbGeAlD
Aprepitant—TACR1—adipose tissue—type 2 diabetes mellitus	0.000725	0.0558	CbGeAlD
Aprepitant—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000665	0.0512	CbGeAlD
Aprepitant—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000569	0.0438	CbGeAlD
Aprepitant—CYP3A7—liver—type 2 diabetes mellitus	0.000434	0.0335	CbGeAlD
Aprepitant—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000369	0.0284	CbGeAlD
Aprepitant—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000342	0.0263	CbGeAlD
Aprepitant—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000275	0.0212	CbGeAlD
Aprepitant—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000243	0.0187	CbGeAlD
Aprepitant—CYP3A5—kidney—type 2 diabetes mellitus	0.000242	0.0186	CbGeAlD
Aprepitant—CYP3A5—pancreas—type 2 diabetes mellitus	0.00024	0.0185	CbGeAlD
Aprepitant—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000236	0.0181	CbGeAlD
Aprepitant—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000218	0.0168	CbGeAlD
Aprepitant—CYP2C19—liver—type 2 diabetes mellitus	0.000194	0.0149	CbGeAlD
Aprepitant—CYP3A4—kidney—type 2 diabetes mellitus	0.000182	0.014	CbGeAlD
Aprepitant—CYP1A2—liver—type 2 diabetes mellitus	0.000159	0.0122	CbGeAlD
Aprepitant—CYP3A5—liver—type 2 diabetes mellitus	0.000153	0.0118	CbGeAlD
Aprepitant—CYP2C9—liver—type 2 diabetes mellitus	0.00015	0.0116	CbGeAlD
Aprepitant—CYP3A4—liver—type 2 diabetes mellitus	0.000115	0.00884	CbGeAlD
Aprepitant—Myalgia—Irbesartan—type 2 diabetes mellitus	6.83e-05	0.000405	CcSEcCtD
Aprepitant—Shock—Metformin—type 2 diabetes mellitus	6.82e-05	0.000405	CcSEcCtD
Aprepitant—Insomnia—Orlistat—type 2 diabetes mellitus	6.81e-05	0.000404	CcSEcCtD
Aprepitant—Malaise—Losartan—type 2 diabetes mellitus	6.8e-05	0.000404	CcSEcCtD
Aprepitant—Anxiety—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000403	CcSEcCtD
Aprepitant—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.8e-05	0.000403	CcSEcCtD
Aprepitant—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.8e-05	0.000403	CcSEcCtD
Aprepitant—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.79e-05	0.000403	CcSEcCtD
Aprepitant—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.79e-05	0.000403	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000402	CcSEcCtD
Aprepitant—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.78e-05	0.000402	CcSEcCtD
Aprepitant—Somnolence—Valsartan—type 2 diabetes mellitus	6.77e-05	0.000401	CcSEcCtD
Aprepitant—Syncope—Losartan—type 2 diabetes mellitus	6.77e-05	0.000401	CcSEcCtD
Aprepitant—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.76e-05	0.000401	CcSEcCtD
Aprepitant—Discomfort—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.0004	CcSEcCtD
Aprepitant—Skin disorder—Metformin—type 2 diabetes mellitus	6.74e-05	0.000399	CcSEcCtD
Aprepitant—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000398	CcSEcCtD
Aprepitant—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.7e-05	0.000398	CcSEcCtD
Aprepitant—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.7e-05	0.000398	CcSEcCtD
Aprepitant—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000397	CcSEcCtD
Aprepitant—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.68e-05	0.000396	CcSEcCtD
Aprepitant—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000396	CcSEcCtD
Aprepitant—Palpitations—Losartan—type 2 diabetes mellitus	6.67e-05	0.000395	CcSEcCtD
Aprepitant—Nausea—Glimepiride—type 2 diabetes mellitus	6.65e-05	0.000394	CcSEcCtD
Aprepitant—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.63e-05	0.000393	CcSEcCtD
Aprepitant—Nausea—Sitagliptin—type 2 diabetes mellitus	6.63e-05	0.000393	CcSEcCtD
Aprepitant—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.62e-05	0.000393	CcSEcCtD
Aprepitant—Asthenia—Glyburide—type 2 diabetes mellitus	6.62e-05	0.000393	CcSEcCtD
Aprepitant—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.62e-05	0.000393	CcSEcCtD
Aprepitant—Anorexia—Metformin—type 2 diabetes mellitus	6.61e-05	0.000392	CcSEcCtD
Aprepitant—Cough—Losartan—type 2 diabetes mellitus	6.58e-05	0.000391	CcSEcCtD
Aprepitant—Urticaria—Gliclazide—type 2 diabetes mellitus	6.58e-05	0.00039	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.57e-05	0.00039	CcSEcCtD
Aprepitant—Alopecia—Ramipril—type 2 diabetes mellitus	6.57e-05	0.00039	CcSEcCtD
Aprepitant—Fatigue—Valsartan—type 2 diabetes mellitus	6.56e-05	0.000389	CcSEcCtD
Aprepitant—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.55e-05	0.000389	CcSEcCtD
Aprepitant—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.55e-05	0.000389	CcSEcCtD
Aprepitant—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.000388	CcSEcCtD
Aprepitant—Oedema—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.000388	CcSEcCtD
Aprepitant—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.54e-05	0.000388	CcSEcCtD
Aprepitant—Pruritus—Glyburide—type 2 diabetes mellitus	6.53e-05	0.000387	CcSEcCtD
Aprepitant—Mental disorder—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000386	CcSEcCtD
Aprepitant—Constipation—Valsartan—type 2 diabetes mellitus	6.51e-05	0.000386	CcSEcCtD
Aprepitant—Infection—Irbesartan—type 2 diabetes mellitus	6.5e-05	0.000386	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.5e-05	0.000385	CcSEcCtD
Aprepitant—Fatigue—Orlistat—type 2 diabetes mellitus	6.49e-05	0.000385	CcSEcCtD
Aprepitant—Hypotension—Metformin—type 2 diabetes mellitus	6.48e-05	0.000384	CcSEcCtD
Aprepitant—Malnutrition—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000384	CcSEcCtD
Aprepitant—Erythema—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000384	CcSEcCtD
Aprepitant—Shock—Irbesartan—type 2 diabetes mellitus	6.44e-05	0.000382	CcSEcCtD
Aprepitant—Pain—Orlistat—type 2 diabetes mellitus	6.43e-05	0.000382	CcSEcCtD
Aprepitant—Arthralgia—Losartan—type 2 diabetes mellitus	6.42e-05	0.000381	CcSEcCtD
Aprepitant—Chest pain—Losartan—type 2 diabetes mellitus	6.42e-05	0.000381	CcSEcCtD
Aprepitant—Myalgia—Losartan—type 2 diabetes mellitus	6.42e-05	0.000381	CcSEcCtD
Aprepitant—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.42e-05	0.000381	CcSEcCtD
Aprepitant—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000381	CcSEcCtD
Aprepitant—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.41e-05	0.00038	CcSEcCtD
Aprepitant—Anxiety—Losartan—type 2 diabetes mellitus	6.4e-05	0.00038	CcSEcCtD
Aprepitant—Tachycardia—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000379	CcSEcCtD
Aprepitant—Rash—Bromocriptine—type 2 diabetes mellitus	6.37e-05	0.000378	CcSEcCtD
Aprepitant—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.36e-05	0.000377	CcSEcCtD
Aprepitant—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000377	CcSEcCtD
Aprepitant—Discomfort—Losartan—type 2 diabetes mellitus	6.35e-05	0.000376	CcSEcCtD
Aprepitant—Dysgeusia—Ramipril—type 2 diabetes mellitus	6.34e-05	0.000376	CcSEcCtD
Aprepitant—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.33e-05	0.000375	CcSEcCtD
Aprepitant—Headache—Bromocriptine—type 2 diabetes mellitus	6.33e-05	0.000375	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.32e-05	0.000375	CcSEcCtD
Aprepitant—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.32e-05	0.000375	CcSEcCtD
Aprepitant—Dry mouth—Losartan—type 2 diabetes mellitus	6.28e-05	0.000373	CcSEcCtD
Aprepitant—Anorexia—Irbesartan—type 2 diabetes mellitus	6.24e-05	0.00037	CcSEcCtD
Aprepitant—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.23e-05	0.000369	CcSEcCtD
Aprepitant—Paraesthesia—Metformin—type 2 diabetes mellitus	6.23e-05	0.000369	CcSEcCtD
Aprepitant—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000369	CcSEcCtD
Aprepitant—Confusional state—Losartan—type 2 diabetes mellitus	6.21e-05	0.000368	CcSEcCtD
Aprepitant—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.2e-05	0.000368	CcSEcCtD
Aprepitant—Dyspnoea—Metformin—type 2 diabetes mellitus	6.18e-05	0.000367	CcSEcCtD
Aprepitant—Somnolence—Metformin—type 2 diabetes mellitus	6.16e-05	0.000366	CcSEcCtD
Aprepitant—Anaphylactic shock—Losartan—type 2 diabetes mellitus	6.16e-05	0.000365	CcSEcCtD
Aprepitant—Oedema—Losartan—type 2 diabetes mellitus	6.16e-05	0.000365	CcSEcCtD
Aprepitant—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.15e-05	0.000365	CcSEcCtD
Aprepitant—Infection—Losartan—type 2 diabetes mellitus	6.12e-05	0.000363	CcSEcCtD
Aprepitant—Hypotension—Irbesartan—type 2 diabetes mellitus	6.11e-05	0.000363	CcSEcCtD
Aprepitant—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.11e-05	0.000362	CcSEcCtD
Aprepitant—Dyspepsia—Metformin—type 2 diabetes mellitus	6.1e-05	0.000362	CcSEcCtD
Aprepitant—Tremor—Ramipril—type 2 diabetes mellitus	6.06e-05	0.00036	CcSEcCtD
Aprepitant—Shock—Losartan—type 2 diabetes mellitus	6.06e-05	0.000359	CcSEcCtD
Aprepitant—Urticaria—Valsartan—type 2 diabetes mellitus	6.05e-05	0.000359	CcSEcCtD
Aprepitant—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.04e-05	0.000358	CcSEcCtD
Aprepitant—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.03e-05	0.000358	CcSEcCtD
Aprepitant—Decreased appetite—Metformin—type 2 diabetes mellitus	6.03e-05	0.000358	CcSEcCtD
Aprepitant—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.02e-05	0.000357	CcSEcCtD
Aprepitant—Tachycardia—Losartan—type 2 diabetes mellitus	6.01e-05	0.000356	CcSEcCtD
Aprepitant—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6e-05	0.000356	CcSEcCtD
Aprepitant—Nausea—Bromocriptine—type 2 diabetes mellitus	6e-05	0.000356	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.99e-05	0.000355	CcSEcCtD
Aprepitant—Fatigue—Metformin—type 2 diabetes mellitus	5.98e-05	0.000355	CcSEcCtD
Aprepitant—Urticaria—Orlistat—type 2 diabetes mellitus	5.98e-05	0.000355	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000354	CcSEcCtD
Aprepitant—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.95e-05	0.000353	CcSEcCtD
Aprepitant—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.95e-05	0.000353	CcSEcCtD
Aprepitant—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.95e-05	0.000353	CcSEcCtD
Aprepitant—Asthenia—Gliclazide—type 2 diabetes mellitus	5.95e-05	0.000353	CcSEcCtD
Aprepitant—Constipation—Metformin—type 2 diabetes mellitus	5.93e-05	0.000352	CcSEcCtD
Aprepitant—Angioedema—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000351	CcSEcCtD
Aprepitant—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.88e-05	0.000348	CcSEcCtD
Aprepitant—Anorexia—Losartan—type 2 diabetes mellitus	5.87e-05	0.000348	CcSEcCtD
Aprepitant—Vomiting—Glyburide—type 2 diabetes mellitus	5.87e-05	0.000348	CcSEcCtD
Aprepitant—Pruritus—Gliclazide—type 2 diabetes mellitus	5.86e-05	0.000348	CcSEcCtD
Aprepitant—Malaise—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000346	CcSEcCtD
Aprepitant—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.83e-05	0.000346	CcSEcCtD
Aprepitant—Rash—Glyburide—type 2 diabetes mellitus	5.82e-05	0.000345	CcSEcCtD
Aprepitant—Somnolence—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000345	CcSEcCtD
Aprepitant—Dermatitis—Glyburide—type 2 diabetes mellitus	5.81e-05	0.000345	CcSEcCtD
Aprepitant—Syncope—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000344	CcSEcCtD
Aprepitant—Headache—Glyburide—type 2 diabetes mellitus	5.78e-05	0.000343	CcSEcCtD
Aprepitant—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.76e-05	0.000342	CcSEcCtD
Aprepitant—Hypotension—Losartan—type 2 diabetes mellitus	5.75e-05	0.000341	CcSEcCtD
Aprepitant—Palpitations—Ramipril—type 2 diabetes mellitus	5.72e-05	0.000339	CcSEcCtD
Aprepitant—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.71e-05	0.000339	CcSEcCtD
Aprepitant—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.69e-05	0.000337	CcSEcCtD
Aprepitant—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.69e-05	0.000337	CcSEcCtD
Aprepitant—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.67e-05	0.000336	CcSEcCtD
Aprepitant—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.67e-05	0.000336	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.65e-05	0.000335	CcSEcCtD
Aprepitant—Cough—Ramipril—type 2 diabetes mellitus	5.65e-05	0.000335	CcSEcCtD
Aprepitant—Fatigue—Irbesartan—type 2 diabetes mellitus	5.64e-05	0.000335	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.61e-05	0.000333	CcSEcCtD
Aprepitant—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.61e-05	0.000333	CcSEcCtD
Aprepitant—Convulsion—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000332	CcSEcCtD
Aprepitant—Pain—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.000332	CcSEcCtD
Aprepitant—Constipation—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.000332	CcSEcCtD
Aprepitant—Insomnia—Losartan—type 2 diabetes mellitus	5.57e-05	0.00033	CcSEcCtD
Aprepitant—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.54e-05	0.000329	CcSEcCtD
Aprepitant—Paraesthesia—Losartan—type 2 diabetes mellitus	5.53e-05	0.000328	CcSEcCtD
Aprepitant—Urticaria—Metformin—type 2 diabetes mellitus	5.51e-05	0.000327	CcSEcCtD
Aprepitant—Arthralgia—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000327	CcSEcCtD
Aprepitant—Chest pain—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000327	CcSEcCtD
Aprepitant—Myalgia—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000327	CcSEcCtD
Aprepitant—Dyspnoea—Losartan—type 2 diabetes mellitus	5.49e-05	0.000326	CcSEcCtD
Aprepitant—Anxiety—Ramipril—type 2 diabetes mellitus	5.49e-05	0.000326	CcSEcCtD
Aprepitant—Nausea—Glyburide—type 2 diabetes mellitus	5.48e-05	0.000325	CcSEcCtD
Aprepitant—Abdominal pain—Metformin—type 2 diabetes mellitus	5.48e-05	0.000325	CcSEcCtD
Aprepitant—Dizziness—Gliclazide—type 2 diabetes mellitus	5.48e-05	0.000325	CcSEcCtD
Aprepitant—Somnolence—Losartan—type 2 diabetes mellitus	5.47e-05	0.000325	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000324	CcSEcCtD
Aprepitant—Asthenia—Valsartan—type 2 diabetes mellitus	5.46e-05	0.000324	CcSEcCtD
Aprepitant—Discomfort—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000323	CcSEcCtD
Aprepitant—Dyspepsia—Losartan—type 2 diabetes mellitus	5.42e-05	0.000322	CcSEcCtD
Aprepitant—Asthenia—Orlistat—type 2 diabetes mellitus	5.4e-05	0.00032	CcSEcCtD
Aprepitant—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.39e-05	0.00032	CcSEcCtD
Aprepitant—Pruritus—Valsartan—type 2 diabetes mellitus	5.39e-05	0.00032	CcSEcCtD
Aprepitant—Dry mouth—Ramipril—type 2 diabetes mellitus	5.39e-05	0.00032	CcSEcCtD
Aprepitant—Decreased appetite—Losartan—type 2 diabetes mellitus	5.35e-05	0.000318	CcSEcCtD
Aprepitant—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000317	CcSEcCtD
Aprepitant—Confusional state—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000316	CcSEcCtD
Aprepitant—Pruritus—Orlistat—type 2 diabetes mellitus	5.32e-05	0.000316	CcSEcCtD
Aprepitant—Fatigue—Losartan—type 2 diabetes mellitus	5.31e-05	0.000315	CcSEcCtD
Aprepitant—Oedema—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000313	CcSEcCtD
Aprepitant—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000313	CcSEcCtD
Aprepitant—Vomiting—Gliclazide—type 2 diabetes mellitus	5.27e-05	0.000313	CcSEcCtD
Aprepitant—Constipation—Losartan—type 2 diabetes mellitus	5.27e-05	0.000312	CcSEcCtD
Aprepitant—Pain—Losartan—type 2 diabetes mellitus	5.27e-05	0.000312	CcSEcCtD
Aprepitant—Rash—Gliclazide—type 2 diabetes mellitus	5.23e-05	0.00031	CcSEcCtD
Aprepitant—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.22e-05	0.00031	CcSEcCtD
Aprepitant—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.21e-05	0.000309	CcSEcCtD
Aprepitant—Urticaria—Irbesartan—type 2 diabetes mellitus	5.2e-05	0.000308	CcSEcCtD
Aprepitant—Shock—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000308	CcSEcCtD
Aprepitant—Headache—Gliclazide—type 2 diabetes mellitus	5.19e-05	0.000308	CcSEcCtD
Aprepitant—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000307	CcSEcCtD
Aprepitant—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.17e-05	0.000307	CcSEcCtD
Aprepitant—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.17e-05	0.000307	CcSEcCtD
Aprepitant—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000307	CcSEcCtD
Aprepitant—Tachycardia—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000306	CcSEcCtD
Aprepitant—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.15e-05	0.000305	CcSEcCtD
Aprepitant—Skin disorder—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000304	CcSEcCtD
Aprepitant—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.1e-05	0.000303	CcSEcCtD
Aprepitant—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.07e-05	0.000301	CcSEcCtD
Aprepitant—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.04e-05	0.000299	CcSEcCtD
Aprepitant—Dizziness—Valsartan—type 2 diabetes mellitus	5.04e-05	0.000299	CcSEcCtD
Aprepitant—Anorexia—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000299	CcSEcCtD
Aprepitant—Dizziness—Orlistat—type 2 diabetes mellitus	4.98e-05	0.000295	CcSEcCtD
Aprepitant—Asthenia—Metformin—type 2 diabetes mellitus	4.98e-05	0.000295	CcSEcCtD
Aprepitant—Hypotension—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000293	CcSEcCtD
Aprepitant—Nausea—Gliclazide—type 2 diabetes mellitus	4.92e-05	0.000292	CcSEcCtD
Aprepitant—Pruritus—Metformin—type 2 diabetes mellitus	4.91e-05	0.000291	CcSEcCtD
Aprepitant—Urticaria—Losartan—type 2 diabetes mellitus	4.89e-05	0.00029	CcSEcCtD
Aprepitant—Body temperature increased—Losartan—type 2 diabetes mellitus	4.87e-05	0.000289	CcSEcCtD
Aprepitant—Abdominal pain—Losartan—type 2 diabetes mellitus	4.87e-05	0.000289	CcSEcCtD
Aprepitant—Vomiting—Valsartan—type 2 diabetes mellitus	4.84e-05	0.000287	CcSEcCtD
Aprepitant—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.82e-05	0.000286	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000285	CcSEcCtD
Aprepitant—Rash—Valsartan—type 2 diabetes mellitus	4.8e-05	0.000285	CcSEcCtD
Aprepitant—Dermatitis—Valsartan—type 2 diabetes mellitus	4.8e-05	0.000284	CcSEcCtD
Aprepitant—Vomiting—Orlistat—type 2 diabetes mellitus	4.78e-05	0.000284	CcSEcCtD
Aprepitant—Insomnia—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000283	CcSEcCtD
Aprepitant—Headache—Valsartan—type 2 diabetes mellitus	4.77e-05	0.000283	CcSEcCtD
Aprepitant—Diarrhoea—Metformin—type 2 diabetes mellitus	4.74e-05	0.000281	CcSEcCtD
Aprepitant—Rash—Orlistat—type 2 diabetes mellitus	4.74e-05	0.000281	CcSEcCtD
Aprepitant—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000281	CcSEcCtD
Aprepitant—Dermatitis—Orlistat—type 2 diabetes mellitus	4.74e-05	0.000281	CcSEcCtD
Aprepitant—Headache—Orlistat—type 2 diabetes mellitus	4.71e-05	0.00028	CcSEcCtD
Aprepitant—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000279	CcSEcCtD
Aprepitant—Asthenia—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000278	CcSEcCtD
Aprepitant—Somnolence—Ramipril—type 2 diabetes mellitus	4.69e-05	0.000278	CcSEcCtD
Aprepitant—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.65e-05	0.000276	CcSEcCtD
Aprepitant—Pruritus—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000275	CcSEcCtD
Aprepitant—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000272	CcSEcCtD
Aprepitant—Dizziness—Metformin—type 2 diabetes mellitus	4.59e-05	0.000272	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.56e-05	0.00027	CcSEcCtD
Aprepitant—Fatigue—Ramipril—type 2 diabetes mellitus	4.55e-05	0.00027	CcSEcCtD
Aprepitant—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.54e-05	0.000269	CcSEcCtD
Aprepitant—Nausea—Valsartan—type 2 diabetes mellitus	4.52e-05	0.000268	CcSEcCtD
Aprepitant—Constipation—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000268	CcSEcCtD
Aprepitant—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.48e-05	0.000266	CcSEcCtD
Aprepitant—Nausea—Orlistat—type 2 diabetes mellitus	4.47e-05	0.000265	CcSEcCtD
Aprepitant—Asthenia—Losartan—type 2 diabetes mellitus	4.42e-05	0.000262	CcSEcCtD
Aprepitant—Vomiting—Metformin—type 2 diabetes mellitus	4.41e-05	0.000261	CcSEcCtD
Aprepitant—Rash—Metformin—type 2 diabetes mellitus	4.37e-05	0.000259	CcSEcCtD
Aprepitant—Dermatitis—Metformin—type 2 diabetes mellitus	4.37e-05	0.000259	CcSEcCtD
Aprepitant—Pruritus—Losartan—type 2 diabetes mellitus	4.36e-05	0.000258	CcSEcCtD
Aprepitant—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000258	CcSEcCtD
Aprepitant—Headache—Metformin—type 2 diabetes mellitus	4.34e-05	0.000258	CcSEcCtD
Aprepitant—Dizziness—Irbesartan—type 2 diabetes mellitus	4.33e-05	0.000257	CcSEcCtD
Aprepitant—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000256	CcSEcCtD
Aprepitant—Diarrhoea—Losartan—type 2 diabetes mellitus	4.21e-05	0.00025	CcSEcCtD
Aprepitant—Urticaria—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000249	CcSEcCtD
Aprepitant—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000248	CcSEcCtD
Aprepitant—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000248	CcSEcCtD
Aprepitant—Vomiting—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000247	CcSEcCtD
Aprepitant—Rash—Irbesartan—type 2 diabetes mellitus	4.13e-05	0.000245	CcSEcCtD
Aprepitant—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.12e-05	0.000244	CcSEcCtD
Aprepitant—Nausea—Metformin—type 2 diabetes mellitus	4.12e-05	0.000244	CcSEcCtD
Aprepitant—Headache—Irbesartan—type 2 diabetes mellitus	4.1e-05	0.000243	CcSEcCtD
Aprepitant—Dizziness—Losartan—type 2 diabetes mellitus	4.07e-05	0.000242	CcSEcCtD
Aprepitant—Vomiting—Losartan—type 2 diabetes mellitus	3.92e-05	0.000232	CcSEcCtD
Aprepitant—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000231	CcSEcCtD
Aprepitant—Nausea—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000231	CcSEcCtD
Aprepitant—Rash—Losartan—type 2 diabetes mellitus	3.88e-05	0.00023	CcSEcCtD
Aprepitant—Dermatitis—Losartan—type 2 diabetes mellitus	3.88e-05	0.00023	CcSEcCtD
Aprepitant—Headache—Losartan—type 2 diabetes mellitus	3.86e-05	0.000229	CcSEcCtD
Aprepitant—Asthenia—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000225	CcSEcCtD
Aprepitant—Pruritus—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000222	CcSEcCtD
Aprepitant—Nausea—Losartan—type 2 diabetes mellitus	3.66e-05	0.000217	CcSEcCtD
Aprepitant—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000214	CcSEcCtD
Aprepitant—Dizziness—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000207	CcSEcCtD
Aprepitant—Vomiting—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000199	CcSEcCtD
Aprepitant—Rash—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000197	CcSEcCtD
Aprepitant—Dermatitis—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000197	CcSEcCtD
Aprepitant—Headache—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000196	CcSEcCtD
Aprepitant—Nausea—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000186	CcSEcCtD
Aprepitant—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	5.44e-06	6.54e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	5.43e-06	6.52e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	5.43e-06	6.52e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	5.43e-06	6.52e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	5.43e-06	6.52e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	5.4e-06	6.49e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	5.34e-06	6.42e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	5.34e-06	6.42e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.3e-06	6.37e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.3e-06	6.37e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	5.28e-06	6.35e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.22e-06	6.27e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	5.2e-06	6.25e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	5.18e-06	6.22e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	5.18e-06	6.22e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	5.17e-06	6.21e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.1e-06	6.13e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.1e-06	6.13e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	5.08e-06	6.11e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	5.08e-06	6.1e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	5.06e-06	6.09e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.05e-06	6.08e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.05e-06	6.07e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	5.04e-06	6.07e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	5.04e-06	6.07e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	5.04e-06	6.07e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	5.01e-06	6.03e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.01e-06	6.02e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	5e-06	6.02e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.98e-06	5.98e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	4.96e-06	5.97e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	4.96e-06	5.97e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	4.96e-06	5.97e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	4.95e-06	5.95e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.92e-06	5.92e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.92e-06	5.92e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.92e-06	5.92e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	4.92e-06	5.92e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.89e-06	5.88e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.87e-06	5.86e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	4.87e-06	5.85e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	4.84e-06	5.81e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.83e-06	5.8e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.8e-06	5.77e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	4.8e-06	5.77e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	4.77e-06	5.74e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.76e-06	5.72e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.72e-06	5.68e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	4.71e-06	5.66e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.63e-06	5.57e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	4.57e-06	5.5e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.54e-06	5.46e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.54e-06	5.46e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.52e-06	5.44e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.52e-06	5.44e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.52e-06	5.44e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.51e-06	5.43e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.49e-06	5.4e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.49e-06	5.4e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	4.45e-06	5.35e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.44e-06	5.34e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.42e-06	5.32e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.42e-06	5.32e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	4.41e-06	5.3e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.4e-06	5.29e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.4e-06	5.29e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.38e-06	5.26e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	4.37e-06	5.25e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.35e-06	5.23e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.34e-06	5.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.34e-06	5.22e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.34e-06	5.21e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	4.33e-06	5.2e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.31e-06	5.19e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.31e-06	5.18e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.31e-06	5.18e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.31e-06	5.18e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.31e-06	5.18e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.3e-06	5.17e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.3e-06	5.17e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.28e-06	5.15e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	4.27e-06	5.14e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	4.26e-06	5.12e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.21e-06	5.06e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.19e-06	5.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.19e-06	5.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.19e-06	5.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.19e-06	5.04e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.16e-06	5e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.15e-06	4.99e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.14e-06	4.98e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.1e-06	4.93e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.09e-06	4.92e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.09e-06	4.92e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.06e-06	4.88e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.01e-06	4.83e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.99e-06	4.8e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.97e-06	4.77e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	3.97e-06	4.77e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	3.93e-06	4.73e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.92e-06	4.72e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.92e-06	4.72e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.88e-06	4.66e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.87e-06	4.65e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.87e-06	4.65e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.87e-06	4.65e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	3.86e-06	4.64e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.79e-06	4.56e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	3.79e-06	4.56e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	3.79e-06	4.56e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.76e-06	4.52e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	3.74e-06	4.49e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.73e-06	4.49e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.71e-06	4.46e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.71e-06	4.46e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.71e-06	4.46e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.69e-06	4.44e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.68e-06	4.43e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	3.67e-06	4.42e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	3.66e-06	4.4e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.64e-06	4.38e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.62e-06	4.35e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.54e-06	4.25e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.54e-06	4.25e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.5e-06	4.2e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.48e-06	4.19e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.47e-06	4.17e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.44e-06	4.14e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.41e-06	4.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.41e-06	4.1e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.41e-06	4.1e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.39e-06	4.08e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.38e-06	4.07e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.38e-06	4.07e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.38e-06	4.06e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.37e-06	4.05e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.35e-06	4.03e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.35e-06	4.03e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.35e-06	4.03e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.33e-06	4e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.33e-06	4e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.33e-06	4e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.32e-06	3.99e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.31e-06	3.98e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.3e-06	3.97e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.29e-06	3.96e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.25e-06	3.9e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.22e-06	3.88e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.21e-06	3.86e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.21e-06	3.86e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.19e-06	3.83e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.17e-06	3.81e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.14e-06	3.77e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.13e-06	3.76e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.08e-06	3.7e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.04e-06	3.65e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.01e-06	3.62e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3e-06	3.61e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.98e-06	3.59e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.98e-06	3.59e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.98e-06	3.59e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.98e-06	3.59e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.93e-06	3.52e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.92e-06	3.52e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.9e-06	3.49e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.89e-06	3.47e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.89e-06	3.47e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.89e-06	3.47e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.89e-06	3.47e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.88e-06	3.46e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.87e-06	3.45e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.84e-06	3.42e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.84e-06	3.41e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.84e-06	3.41e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.83e-06	3.4e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.8e-06	3.36e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.77e-06	3.33e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.75e-06	3.31e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.74e-06	3.3e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.74e-06	3.3e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.73e-06	3.28e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.72e-06	3.27e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.7e-06	3.24e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.7e-06	3.24e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.68e-06	3.22e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.63e-06	3.17e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.63e-06	3.16e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.59e-06	3.11e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.59e-06	3.11e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.59e-06	3.11e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.58e-06	3.1e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.57e-06	3.1e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.57e-06	3.09e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.55e-06	3.07e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.51e-06	3.02e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.5e-06	3.01e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.47e-06	2.97e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.46e-06	2.96e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.42e-06	2.91e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.37e-06	2.85e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.32e-06	2.79e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.25e-06	2.71e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.25e-06	2.7e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.23e-06	2.68e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.23e-06	2.68e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.22e-06	2.67e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.22e-06	2.66e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.21e-06	2.66e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.2e-06	2.65e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.2e-06	2.65e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.19e-06	2.63e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.18e-06	2.62e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.13e-06	2.56e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.12e-06	2.55e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.12e-06	2.55e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.07e-06	2.49e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.03e-06	2.44e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.02e-06	2.43e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.99e-06	2.39e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.98e-06	2.38e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.94e-06	2.33e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.93e-06	2.32e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.93e-06	2.32e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.93e-06	2.32e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.92e-06	2.31e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.9e-06	2.29e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.88e-06	2.26e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.83e-06	2.2e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.79e-06	2.16e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.77e-06	2.13e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.74e-06	2.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.74e-06	2.09e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.73e-06	2.08e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.71e-06	2.05e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.7e-06	2.05e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.68e-06	2.02e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.65e-06	1.99e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.65e-06	1.99e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.51e-06	1.82e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.48e-06	1.78e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.45e-06	1.75e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.33e-06	1.6e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.27e-06	1.53e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.27e-06	1.53e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.26e-06	1.52e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-06	1.4e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.74e-07	1.17e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	8.88e-07	1.07e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	7.59e-07	9.13e-06	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.86e-07	7.05e-06	CbGpPWpGaD
